News Briefing channel feed – Endpoints News

News Briefing channel feed

J&J disputes report it’s dropping JLabs plans for UK; Takeda takes Zika vaccine into PhI

8 years ago

Vir chief Scangos picks Herbert ‘Skip’ Virgin to run R&D; Ardelyx forges $160M deal with Kyowa Hakko Kirin

8 years ago

Intrexon taps new COO, CBO in executive reshuffle; Denali targets up to $182M in IPO

8 years ago

Open plan designs: The good, the bad and the ugly; Fresenius adding 400-plus staffers

8 years ago

Jeff Capello joins Biogen as CFO; Tesaro enters $500M loan agreement; Palatin licenses female libido drug to Korea's Kwangdon

8 years ago

Promentis closes $26M round and enters clinic; PellePharma gets breakthrough/orphan status; Shire appoints Dittrich as CFO

8 years ago

UK research campus expands; FDA clears NGS test for tumors; Orphazyme raises €80 million IPO

8 years ago

Merck partners up on T-cell tech platform in $374M autoimmune deal; Turnstone taps BMS vet Mike Burgess for top R&D role

8 years ago

Moderna kicks off mRNA cancer vaccine study; Biotech stocks were checked this month -- but that's a good thing

8 years ago

Parker Institute, MD Anderson and Seres developing a microbiome/PD-1/L1 combo; CRISPR-Cas antimicrobial biotech Locus raises $17M

8 years ago

Alnylam's patisiran grabs EMA accelerated review; CRISPR Therapeutics, Casebia enter mRNA deal with CureVac

8 years ago

Roche gets EMA recommendation for Ocrevus; Anthem now covers Sarepta's exon-skipping Duchenne MD drug

8 years ago

Mary Szela resigns as CEO of Novelion; China is proving to be a rewarding market for AstraZeneca

8 years ago

Boehringer strikes €307M collaboration deal with MiNA; Tricida banks $57.5M venture round for PhIII

8 years ago

Mumbai-based Lupin gets FDA warning for two manufacturing sites; Ionis promotes inotersen head as new COO

8 years ago

Novartis pitches two new CAR-T applications to EMA; J&J reports positive data for lupus program

8 years ago

Former Puma exec agrees to prison time, penalty on insider trading case; Ex-GSK boss Witty to lead UK’s new ‘breakthrough’ program

8 years ago

Focusing on next-gen cancer drugs, GSK touts a ‘breakthrough’ at FDA; Aisling raises $280M fund

8 years ago

Regeneron, Sanofi rack up a PhIII asthma win for dupilumab; Verastem preps FDA app for duvelisib

8 years ago

Mereo bags rights to the latest AstraZeneca castoff, shifts focus; Neos rejects buyout offer

8 years ago

Tocagen streamlines pivotal plans; Wave Life Sciences cuts ribbon on new manufacturing plant

8 years ago

Tesaro wins FDA OK for an IV version of chemo drug, launches discovery deal with Evotec

8 years ago

PDUFA date past, PTC still hasn’t said what the FDA’s verdict was; BioInvent searching for a new CEO

8 years ago

Imprimis spins out a new biotech focused on eye drugs; Alzheimer’s groups back PhII study at Amylyx

8 years ago

First page Previous page 64 65 666768 69 70 Next page Last page